ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0015

Profiling of B and T Cells in Kidney Biopsies from ANCA-associated Vasculitis Patients with Glomerulonephritis at Single-Cell Resolution

Ana Merino Vico1, Yosta Vegting1, Aldo Jongejan1, Jan Piet van Hamburg1, Perry moerland1, Sander Tas2 and Marc Hilhorst1, 1Amsterdam UMC, Amsterdam, Netherlands, 2Amsterdam UMC, locatie AMC, Amsterdam, Netherlands

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, B-Lymphocyte, Bioinformatics, T-Lymphocyte, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small-vessel autoimmune vasculitis, associated with severe lung and kidney impairment. B cells are crucial in AAV pathogenesis, further demonstrated by the beneficial clinical effects of rituximab (anti-CD20 B cell targeted) therapy. However, B lineage cell studies in AAV mostly rely on the peripheral blood, emphasizing the need to characterize these populations and their T cell counterparts in other compartments of the immune system and in the target tissues to understand their role in the pathogenesis. 

We aim to profile immune cells at single-cell resolution inkidney biopsies from AAV patients with active disease and a nephrectomy control, studying the resulting clusters of B and T lineage cells.

Methods: Core-needle kidney biopsies were obtained from 4 patients with AAV glomerulonephritis and a nephrectomy control. Live CD45+ immune cells from the kidney were sorted and processed for single-cell data generation and analysis. Annotation was based on the mature immune kidney cell atlas.

Results: We identified 24 clusters from which we focused on the main players of adaptive immunity: B and T lineage cells. Two B cell enriched clusters (based on CD19/CD20 expression; 5.07% of total) and one plasmablast/plasma cell cluster (based on CD38/CD138 expression; 0.45% of total) were re-clustered for further analysis. We obtained 4 subpopulations at low resolution, annotated as memory B cells (MS4A1, CD19, CD27, PAX5), naïve B cells (MS4A1, CD19, IGHD), plasmablast-like (MS4A1, CD19, CD27, TNFRSF13C, XBP1), and plasma cells (CD38, SDC1, IRF4, XBP1, PRDM1). The relative mean frequencies of the B lineage populations were 51.20% memory, 38.72% naïve , 5.24% plasmablasts, and 4.85% plasma cells. With higher resolution, 3 different subtypes of memory B cells were observed, in addition to 3 naïve/germinal center-like B cells, and the 2 previously well-defined plasmablast and plasma cell clusters. We identified 11 T cell enriched clusters (based on CD3 expression; 61.35% of total) and three NK/NKT cell clusters (based on CD16 expression; 14.24% of total), which were further re-clustered. Low resolution clustering resulted in 4 CD4 T cell clusters, 4 CD8 T cell clusters and 2 NK/NKT cell clusters, with a relative mean frequency of 34.06%, 50.19% and 15.75%, respectively. An increased resolution revealed 8 CD4 subpopulations, including one Treg cluster (based on FOXP3 and CTLA4 expression) and one T helper-like cluster (based on PDCD1 and CD40LG expression); 8 CD8 subpopulations, including one TEMRA-like subset (based on CD45RA, GZMH, GNLY, PRF1 expression); and 3 NK subclusters.

Conclusion: Our preliminary data profiles, for the first time, B and T cell populations in kidney biopsies from AAV patients with glomerulonephritis at single-cell resolution. Comprehensive examination of these clusters may reveal (pathogenic) subsets potentially specific for AAV or ANCA subtype that may contribute to kidney involvement. Subsequent gene set enrichment analysis may identify differential gene expression patterns and intracellular signalling pathways involved, offering potential targets for more directed therapies.


Disclosures: A. Merino Vico: None; Y. Vegting: None; A. Jongejan: None; J. van Hamburg: None; P. moerland: None; S. Tas: None; M. Hilhorst: None.

To cite this abstract in AMA style:

Merino Vico A, Vegting Y, Jongejan A, van Hamburg J, moerland P, Tas S, Hilhorst M. Profiling of B and T Cells in Kidney Biopsies from ANCA-associated Vasculitis Patients with Glomerulonephritis at Single-Cell Resolution [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/profiling-of-b-and-t-cells-in-kidney-biopsies-from-anca-associated-vasculitis-patients-with-glomerulonephritis-at-single-cell-resolution/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/profiling-of-b-and-t-cells-in-kidney-biopsies-from-anca-associated-vasculitis-patients-with-glomerulonephritis-at-single-cell-resolution/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology